INSIGHTS ON DRUG DEVELOPMENT
-
![GettyImages-1173354781 protein degradation]( "Accelerating Small Molecule Protein Degrader Development Using High-Content Imaging")
Accelerating Small Molecule Protein Degrader Development Using High-Content ImagingHigh‑content imaging enables rapid discovery and optimization of small‑molecule protein degraders by delivering multiparametric, single‑cell insights that accelerate hit identification, SAR development, and lead advancement.
-
![GettyImages-2194013442-laboratory-scientists-computer-evaluating]( "5 Key Considerations For Companies Outsourcing Process Development")
5 Key Considerations For Companies Outsourcing Process DevelopmentVenture capital in biotech remains strong post-pandemic, especially in cell and gene therapies. Discover five key factors to help companies choose between in-house and outsourced process development strategies.
-
![formulation strategies]( "Formulation Strategies For Enabling \"Undevelopable\" Compounds")
Formulation Strategies For Enabling "Undevelopable" CompoundsKinetiSol enhances bioavailability of poorly soluble drugs like Vemurafenib by producing dense amorphous dispersions, outperforming traditional MBP methods in pharmacokinetics and dissolution.
-
![GettyImages-1354172647-scientist-in-lab-with-flasks-pipette]( "NGS In GMP Manufacturing: Reducing Risk, Increasing Return")
NGS In GMP Manufacturing: Reducing Risk, Increasing ReturnGlobal regulators now recognize NGS as a rigorous, GMP‑ready tool for viral safety, driving a shift toward scalable quality strategies. Learn why NGS is becoming central to modern manufacturing.
-
Bridging Development And Manufacturing For Better Outcomes8/31/2026
Learn how integrated formulation, analytical, and manufacturing strategies help overcome development challenges and advance drug candidates from early stages to commercialization.
-
Overcoming API Constraints And Tight Timelines With On-Demand Manufacturing3/20/2026
Use innovative lipid-based formulations and on-demand manufacturing to accelerate Phase 1 trials, enable flexible dose escalation, and maximize limited API for poorly soluble compounds.
-
API Solubility And Dissolution Enhancement Via Formulation6/4/2025
Solubility and dissolution rate of an API are essential for effective oral drug absorption. Discover how these factors directly influence bioavailability, which determines how much and how quickly a drug enters circulation.
-
How Is Peptide Crystallization Screening Used In Peptide-Based Therapeutic Development?7/24/2026
Hannah McLachlan, Project Scientist IV at Cambrex Edinburgh, on what crystallization screening delivers for peptide therapeutics — more stable material, higher purity, and a molecule clients can store without specialist infrastructure.
-
Mobile Minor Process Explanation4/28/2026
Dr. Jordan Potts explains how the Mobile Minor spray dryer works and outlines its role in spray drying and particle engineering research applications.
DRUG DEVELOPMENT SOLUTIONS
-
![scientist in lab microscope-GettyImages-1867575565]( "Deformulate And Identify MS Components")
Gain insight into how faster structural elucidation is possible with integrated mass spectrometry workflows that combine intelligent data analysis, spectral matching, and automation.
-
![molecular-devices-pclamp-11-software-suite]( "Sophisticated Patch-Clamp Electrophysiology Data Acquisition And Analysis Software")
Preconfigured protocols and custom assay workflows simplify microplate data acquisition and analysis
SoftMax® Pro Software for Windows 10 is designed to provide the simplicity, flexibility and power required for advanced data analysis. It provides ready-to-run protocols, analysis algorithms, and 21 different curve fit options.
-
![molecular-devices-micro-confocal-imaging-system]( "Unique Confocal Imaging Solutions")
Unique confocal imaging solution capable of imaging more than a million wells a week
The ImageXpress® Micro Confocal system is a high-content solution that can switch between widefield and confocal imaging of fixed and live cells.
-
![GettyImages-1214921728-lab-glassware-beaker-vial-test-tube]( "Enhance The Solubility Of Your APIs With AI")
When it comes to solid dosage formulations, the most common challenge formulators face is poor solubility. In numbers: 70% of drugs in development are poorly soluble.
-
![AccuSEQ]( "From Process Development To QC—Optimize Your mAbs Workflow")
See how integrated analytical capabilities help improve visibility across mAb workflows, enabling faster decisions, stronger process control, and reliable quality outcomes from development through QC.
